These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9148147)

  • 1. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Devereaux PJ; Ghali WA
    N Engl J Med; 1997 May; 336(20):1452-3; author reply 1453-4. PubMed ID: 9148147
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Petros JA
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148146
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Reis SE; Feldman AH
    N Engl J Med; 1997 May; 336(20):1453; author reply 1453-4. PubMed ID: 9148148
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group.
    Mangano DT; Layug EL; Wallace A; Tateo I
    N Engl J Med; 1996 Dec; 335(23):1713-20. PubMed ID: 8929262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
    Ho T; Taussig D; McAnulty G
    N Engl J Med; 1997 May; 336(20):1452; author reply 1453-4. PubMed ID: 9148145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Still uncertainty about the usefulness of perioperative beta-blockade. Conclusive studies concerning patients with cardiovascular risk factors not available].
    Gannedahl P
    Lakartidningen; 2006 Sep 13-19; 103(37):2638-40, 2643. PubMed ID: 17022183
    [No Abstract]   [Full Text] [Related]  

  • 7. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
    Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing cardiovascular risk in patients undergoing noncardiac surgery.
    Eagle KA; Froehlich JB
    N Engl J Med; 1996 Dec; 335(23):1761-3. PubMed ID: 8929270
    [No Abstract]   [Full Text] [Related]  

  • 10. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quo vadis, perioperative beta blockade? Are you "POISE'd" on the brink?
    London MJ
    Anesth Analg; 2008 Apr; 106(4):1025-30. PubMed ID: 18349169
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale, design, and organization of the PeriOperative ISchemic Evaluation (POISE) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery.
    ; Devereaux PJ; Yang H; Guyatt GH; Leslie K; Villar JC; Monteri VM; Choi P; Giles JW; Yusuf S
    Am Heart J; 2006 Aug; 152(2):223-30. PubMed ID: 16875901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atenolol for prevention of postsurgical cardiovascular events.
    Shapley-Quinn K; Newton W
    J Fam Pract; 1997 Mar; 44(3):243, 247. PubMed ID: 9071238
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Mar; 49(3):203-4. PubMed ID: 10735475
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
    Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
    Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-blocker therapy and risk reduction in non-cardiac surgery].
    Passamonti E; Pirelli S
    Ital Heart J Suppl; 2003 Feb; 4(2):96-101. PubMed ID: 12762258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of acute coronary events in noncardiac surgery: beta-blocker therapy and coronary revascularization.
    Flu WJ; van Kuijk JP; Winkel T; Hoeks S; Bax J; Poldermans D
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):521-32. PubMed ID: 19419260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker therapy in noncardiac surgery.
    Poldermans D; Boersma E
    N Engl J Med; 2005 Jul; 353(4):412-4. PubMed ID: 16049214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postoperative cardiac morbidity/mortality in high-risk elderly patients undergoing non-cardiac surgery].
    de la Cruz Pérez C; Estecha Foncea MA; Cruz Mañas J; Castillo Caparrós A; Palma Pérez F; Sarmiento Pardo J
    Rev Esp Anestesiol Reanim; 1999 Jan; 46(1):4-8. PubMed ID: 10073077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.